SMTL ID : 7q27.1

Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD011

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.50 Å

Oligo State

monomer

Ligands

1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-FUC.1: 9 residues within 4Å: Chain A: S.9, V.12, E.13, N.73, T.75, I.76, L.361, P.362, L.365 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:V.12, A:E.13 Hydrogen bonds: A:E.13, A:E.13 Water bridges: A:T.75

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.2: 6 residues within 4Å: Chain A: N.36, T.38, E.40, T.41, D.310, R.312 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.36 Water bridges: A:R.312

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.3: 7 residues within 4Å: Chain A: N.30, S.319, A.320, W.321, D.322 Ligands: EDO.5, 8KC.8 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:N.30, A:A.320 EDO.4: 8 residues within 4Å: Chain A: Y.33, I.37, T.38, T.39, S.42, K.101, L.104, T.108 No protein-ligand interaction detected (PLIP) EDO.5: 8 residues within 4Å: Chain A: A.320, H.351, F.355, H.374, E.375, R.486 Ligands: EDO.3, 8KC.8 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:A.320, A:A.320 Water bridges: A:E.375

1 x ACT: ACETATE ION(Non-functional Binders)

ACT.6: 7 residues within 4Å: Chain A: Y.214, R.221, V.255, P.256, W.566, E.570, H.574 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.570 Water bridges: A:R.221

1 x ZN: ZINC ION(Non-covalent)

ZN.7: 5 residues within 4Å: Chain A: H.347, H.351, E.375, Y.487 Ligands: 8KC.8 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:H.347, A:H.351, A:E.375

1 x 8KC: (2~{S})-2-[[(2~{S})-1-[[(2~{S})-3-(1~{H}-indol-3-yl)-1-oxidanyl-1-oxidanylidene-propan-2-yl]amino]-1-oxidanylidene-hexan-2-yl]amino]-4-phenyl-butanoic acid(Non-covalent)

8KC.8: 26 residues within 4Å: Chain A: E.126, Q.245, T.246, H.317, A.318, S.319, V.343, V.344, H.347, E.348, H.351, E.375, D.379, F.421, K.475, F.476, H.477, V.482, Y.484, R.486, Y.487, F.491 Ligands: EDO.3, EDO.5, ZN.7, BO3.13 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:V.344, A:H.347, A:F.421, A:F.476, A:V.482, A:Y.487 Hydrogen bonds: A:Q.245, A:A.318, A:A.318, A:H.477, A:Y.484, A:Y.484, A:Y.487 Water bridges: A:K.475, A:K.475 Salt bridges: A:H.317, A:H.347, A:H.351, A:K.475, A:H.477 pi-Stacking: A:H.347

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.9: 6 residues within 4Å: Chain A: W.146, R.150, W.449, W.450, R.453, D.471 Ligand excluded by PLIP CL.10: 6 residues within 4Å: Chain A: M.187, Y.188, P.371, P.483, I.485, R.486 Ligand excluded by PLIP

5 x BO3: BORIC ACID(Non-covalent)

BO3.11: 10 residues within 4Å: Chain A: Y.251, S.262, P.388, L.397, E.400, H.406, N.409, F.410, K.413 Ligands: 1PE.16 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:Y.251, A:Y.251 Water bridges: A:Y.251, A:E.400, A:E.400 BO3.12: 6 residues within 4Å: Chain A: D.85, E.87, A.172, N.175, Y.177, S.183 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:E.87, A:E.87, A:E.87, A:E.87, A:N.175, A:S.183 Water bridges: A:A.172, A:W.184 BO3.13: 9 residues within 4Å: Chain A: Y.110, L.125, E.126, T.130, W.243, H.317, K.475, F.476 Ligands: 8KC.8 5 PLIP interactions: 5 interactions with chain A Hydrogen bonds: A:H.317 Water bridges: A:Y.110, A:K.475, A:K.475, A:F.476 BO3.14: 5 residues within 4Å: Chain A: W.23, Y.26, N.49, I.52, R.88 6 PLIP interactions: 6 interactions with chain A Hydrogen bonds: A:Y.26, A:N.49, A:N.49 Water bridges: A:Y.26, A:R.88, A:N.100 BO3.15: 4 residues within 4Å: Chain A: F.257, D.404, I.408, W.566 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:D.404

1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)

1PE.16: 15 residues within 4Å: Chain A: S.248, N.249, Y.251, S.262, T.265, T.266, L.339, V.343, S.386, L.391, L.397, F.410, K.413, M.414 Ligands: BO3.11 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.413 Water bridges: A:T.265, A:T.266, A:D.417

1 x IMD: IMIDAZOLE(Non-covalent)

IMD.17: 8 residues within 4Å: Chain A: E.147, D.151, R.155, V.463, P.464, R.465, T.466, D.469 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.465, A:R.465, A:T.466, A:D.469

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Arendse, L.B. et al., Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition. J.Med.Chem. (2022)

Release Date

2022-02-16

Peptides

Angiotensin-converting enzyme: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Angiotensin-converting enzyme

Related Entries With Identical Sequence